Remove 2013 Remove Clinical Trials Remove Medicine Remove Patients
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Timeline of Medicinal Legalization in Canada. 01.015 of the FDR before providing the new drug to a patient. Pursuant to subsection C.08.010(1)

Therapy 52
article thumbnail

Medical Marijuana Can Help with the Effects of Traumatic brain injury

FloridaMarijuana.net

The University of Maryland School of Medicine (UMSOM) published a paper detailing the inadequacies of current research. Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients.

Marijuana 190
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Press Release: Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2

Cannabis Law Report

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

article thumbnail

Urge Kentucky Lawmakers to Support Medical Cannabis Reform Today!

NORML

A medical cannabis bill has been filed in the Kentucky General Assembly every year since 2013. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online. Sadly, it seems Stivers already has an answer for would-be medical cannabis patients.

Data 189
article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

Research opportunities such as the ORR expand the existing scientific knowledge base to better inform clinical decision making, and also dispels the stigma surrounding medicinal cannabis use.”. This study represents a refreshing collaboration of scientists, clinicians, patients and advocates. About Realm of Caring.

Data 105
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS. Rick Doblin, Ph.D.,

article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Psychedelics, medicine and ethics has always been a tricky thing and we’re suprised (or maybe not) that those who have held themselves up to be the paragons of perfection in the field over the past few years, have in fact been either arrogant, dumb or lazy when it comes to managing ethics at their organisations.